CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2015 |
Jun. 30, 2014 |
Jun. 30, 2015 |
Jun. 30, 2014 |
Dec. 31, 2014 |
Dec. 31, 2013 |
|
| NET REVENUE | $ 5,966,204 | $ 2,612,202 | $ 12,104,063 | $ 5,185,679 | $ 18,303,264 | $ 10,472,751 |
| OPERATING EXPENSES: | ||||||
| Direct operating costs | 2,913,470 | 1,111,691 | 6,459,678 | 2,264,326 | 10,636,851 | 4,272,979 |
| Selling and marketing | 97,002 | 44,837 | 217,433 | 114,858 | 253,280 | 248,975 |
| General and administrative | 3,176,712 | 1,447,083 | 6,319,384 | 2,733,359 | 9,942,600 | 4,743,673 |
| Research and development | 165,248 | 126,113 | 330,175 | 242,541 | 531,676 | 386,109 |
| Change in contingent consideration | (87,054) | 0 | (915,815) | 0 | (1,811,362) | 0 |
| Depreciation and amortization | 1,202,381 | 271,078 | 2,361,924 | 541,121 | 2,791,368 | 948,531 |
| Total operating expenses | 7,467,759 | 3,000,802 | 14,772,779 | 5,896,205 | 22,344,413 | 10,600,267 |
| Operating loss | (1,501,555) | (388,600) | (2,668,716) | (710,526) | (4,041,149) | (127,516) |
| OTHER: | ||||||
| Interest income | 7,073 | 4,116 | 13,986 | 7,105 | 26,605 | 23,929 |
| Interest expense | (43,687) | (51,448) | (85,872) | (104,161) | (183,466) | (160,065) |
| Other (expense) income - net | 57,213 | 17,731 | 103,359 | (182,154) | (134,715) | 230,146 |
| LOSS BEFORE INCOME TAXES | (1,480,956) | (418,201) | (2,637,243) | (989,736) | (4,332,725) | (33,506) |
| INCOME TAX PROVISION (BENEFIT) | 6,422 | (128,800) | 16,045 | (316,663) | 176,525 | 144,490 |
| NET LOSS | $ (1,487,378) | $ (289,401) | $ (2,653,288) | $ (673,073) | $ (4,509,250) | $ (177,996) |
| NET LOSS PER SHARE: | ||||||
| Basic and diluted loss per share (in dollars per share) | $ (0.15) | $ (0.06) | $ (0.27) | $ (0.13) | $ (0.64) | $ (0.03) |
| Weighted-average basic and diluted shares outstanding (in shares) | 9,719,858 | 5,101,770 | 9,703,568 | 5,101,770 | 7,084,630 | 5,101,770 |
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate direct operating costs incurred during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Interest expense on all other items not previously classified. For example, includes dividends associated with redeemable preferred stock of a subsidiary that is treated as a liability in the parent's consolidated balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets not separately disclosed. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|